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USE OF PRO INSTRUMENTS: COPYRIGHT ISSUES
Anfray C, Emery MP
Mapi Research Trust, Lyon, France
OBJECTIVES: To meet the continuing demand for PRO instru-
ments in clinical research and practice more and more PRO
instruments are being developed. Although the prerequisite for
international pooling and comparison of data is an identiﬁable
original instrument and an ofﬁcial translation in a given lan-
guage, this is not always the case. The need to modify instru-
ments and the emergence of item banks make it difﬁcult to
identify an original instrument and the access to it is complicated
as international copyright law is not sufﬁciently clear on this
point. The objective of this abstract is to review the issues
encountered by our distribution centre when disseminating
instruments and their translations in collaboration with their
developers and to provide recommendations for those who wish
to develop an instrument, access it, use and/or modify it.
METHODS: To establish recommendations we proceeded as
follows: 1) review of all requests to access, use and/ or modify
an instrument or its translations; 2) classiﬁcation of requests, and
3) recommendations. RESULTS: Out of the 2679 requests con-
cerning PRO instruments in 2006, 6 types of questions emerge
to what are the conditions to: 1) access; 2) translate; 3) repro-
duce; 4) use in e-application; 5) modify; 6) use selected items of
a given instrument. In response to this international copyright
law needs to be interpreted and solutions for conﬂicting laws
across countries must be found. Concrete examples will be pro-
vided in the presentation. CONCLUSION: Despite its impor-
tance for clinical research the identiﬁcation of and access to an
original instrument and its translations is not easy. This is com-
plicated by the emerging need to modify instruments and the
absence of clear indications by international copyright law. Our
ﬁndings indicate the importance of questionnaire distribution
centres as a step in the direction of solving copyright issues.
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HOW GOOD IS GOOD ENOUGH? INTERNAL VALIDITY OF
STATED PREFERENCES FOR DRUG THERAPIES
Ozdemir S, Mohamed AF, Huiber G, Johnson FR
Research Triangle Institute, Research Triangle Park, NC, USA
OBJECTIVES: To compare measures of internal validity across
similar stated-choice surveys, evaluate consequences of inconsis-
tencies, and determine whether there is a basis for establishing a
minimum standard for validity. METHODS: Axioms of utility
theory require that valid preferences be stable, monotonic, and
transitive. Counts of validity failures were obtained for each
survey respondent in 8 stated-choice or discrete-choice experi-
ment surveys. Each survey was administered to adults who were
diagnosed with a speciﬁc disease. Each survey required respon-
dents to choose between 8 to 12 pairs of treatment alternatives
with varying treatment features. We also identiﬁed respondents
with non-compensatory or lexicographic preferences, where sub-
jects choose alternatives based on a single attribute. Using neg-
ative-binomial regression we estimated the effect of personal
characteristics on internal-validity test results. RESULTS:
Choices from 3929 respondents were evaluated for internal
validity. Across all surveys, approximately 20% failed at least
one stability test, 10% failed at least one monotonicity test and
15% exhibited lexicographic preferences. Non-white respon-
dents (p < 0.05) and respondents with less education (p < 0.05)
were more likely to fail one of these tests. The effect of income
is concave. As income increases the likelihood of failure of one
or more tests decreases; however, above an annual income of
$100,000, the likelihood of failure increases. Gender, age and
employment had no signiﬁcant effect on internal validity. With
the exception of respondents with lexicographic preferences,
removing respondents who fail internal validity tests generally
did not materially change point estimates in preference models.
However, removing inconsistent respondents improved estimate
precision by 1–5%. CONCLUSION: Our results suggest that a
failure of non-lexicographic internal validity tests at a rate less
than 25% does not bias preference estimates derived from stated-
choice surveys. Identifying which respondent groups ﬁnd stated-
choice surveys challenging can help in developing and pretesting
surveys that minimize cognitive errors in those groups.
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CROSS-OVER RANDOMIZED CONTROL TRIAL OF
ELECTRONIC MEASUREMENT OF HEALTH-RELATED
QUALOITY OF LIFE IN CHINA
Chen T1, Li L1, Du Y1, Lei J2
1Zhejiang University, Hangzhou, China, 2University of Goettingen,
Goettingen, Germany
OBJECTIVES: Veriﬁcation of the feasibility and reliability of the
electronic version of Chinese SF-36 (based on the Quality-of-
Life-Recorder) before its wide deployment. METHODS: Cross-
over randomized controlled trial, comparing a paper based and
an electronic version of the SF-36. According to generated
random numbers, interviewees were asked to ﬁll out either the
electronic version or the paper version ﬁrst. The second version
was ﬁlled in after a pause of at least 30 minutes (medical stu-
dents), or at least 10 minutes (patients). Convenience sample
consisted of one group of 50 medical students and the other
group of 100 patients. RESULTS: The acceptance of the elec-
tronic version was good (60% of medical students and 84% of
patients preferred the electronic version). At the level of eight-
scale scores, the mean-difference for each scale (except for
General Health) between the two versions was less than 5%. At
the level of 36 questions, the percentage of “Exact Agreement”
ranged within 64–99%; the percentage of “Global Agreement”
ranged within 72–99%; 77% of the Kappa coefﬁcients demon-
strated “good/excellent agreement” and 23% of the Kappa coef-
ﬁcients demonstrated “medium agreement”. CONCLUSION:
Our ﬁndings support the feasibility and acceptance of an elec-
tronic version of the Chinese SF-36, as well as the agreement of
results collected with paper-based and electronic version. The
electronic versions may contribute to widespread deployment of
this questionnaire.
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FEASIBILITY,VALIDITY AND RELIABILITY OF THE WELSH
VERSION OF THE EQ-5D HEALTH STATUS QUESTIONNAIRE
Hughes D
University of Wales, Bangor, Bangor, UK
OBJECTIVES: To investigate the feasibility, validity and relia-
bility of the Welsh language version of the EQ-5D in a random
adult population sample in Welsh-speaking areas of Wales.
METHODS: 1000 names were selected at random from electoral
registries, and questionnaires that included the Welsh version of
the EQ-5D together with questions on socio-economic, demo-
graphic and health status, were mailed. Subjects were asked to
rate their health on the day of completion. Respondents to the
ﬁrst questionnaire were sent a second EQ-5D within a fortnight
to assess test-retest reliability. A reminder was sent if the second
questionnaire was not returned within a fortnight. A pre-paid
envelope was provided in each case. The acceptability and fea-
sibility was assessed by examining the number of missing
responses on returned forms. A reliability analysis was con-
ducted, following the test-retest procedure, and construct valid-
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ity was assessed in terms of convergent validity. RESULTS: 126
subjects returned the ﬁrst questionnaire, of which 113 completed
the second. Women represented 59.9% of the sample, and
respondents’ mean age was 56.8 +/− 18 years. 38.7% of subjects
reported having chronic illness. The number of missing items
from the descriptive EQ-5D (aggregated for both administra-
tions) was 4, representing 0.33% of all responses. Five EQ-VAS
responses were returned incomplete. 97 (85.8%) respondents
reported no change in health in the fortnight between the ﬁrst
and second administration. The Spearman rank coefﬁcients for
these respondents were 0.828 for EQ-5D scores, and 0.815 for
EQ-VAS, respectively (both p < 0.000). The results of the regres-
sion analysis for convergent validity suggested that, together,
EQ-VAS score, self-reported health (5-point Likert scale; poor to
excellent), presence of chronic illness, and receipt of treatment,
explained 66.0% of the variation in EQ-5D scores. CONCLU-
SION: It is concluded that the Welsh version of the EQ-5D has
good acceptability, validity and reliability in measuring health
status in subjects across Wales.
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TRADING HEALTH VALUES IN CHILE AND THE US USING 
EQ-5D
Kind P1, Zarate V2, Olivares-Tirado P3
1Outcomes Research Group, Centre for Health Economics, University
of York,York, UK, 2Pontiﬁcia Universidad Catolica de Chile, Santiago,
Chile, 3Superintendencia de Salud, Santiago, Chile
OBJECTIVES: An understanding of the exchange rate in health
values is a necessary requirement to the transfer of health out-
comes data across national borders. As a preliminary to study-
ing the valuation data for EQ-5D health states in US and Chile
it is useful to establish the comparability in values for self-
reported health in the two countries. METHODS: EQ-5D is a
generic, single index measure of health-related quality of life. It
was included as part of a national valuation study conducted in
the US in 2003 that elicited responses from a subgroup of 1216
Hispanics aged 18 and over. Similar data using EQ-5D was col-
lected in a national survey of health in Chile (n = 4258). All
respondents were assigned to a unique EQ-5D health state
deﬁned by their level of reported problem on the 5 dimensions.
The mean visual analogue scale (VAS) score for each of these
health states was computed from respondents’ rating of their
own health status on a 0–100 scale (EQ-5DVAS). Mean EQ-5DVAS
scores for each available EQ-5D health state were compared
across the 2 country samples. RESULTS: The value of self-
assessed health status was generally higher in the US Hispanic
subgroup than for the same EQ-5D health state in the Chilean
survey with a mean absolute difference of 8.5. A linear regres-
sion model used to examine the relationship between values for
the most prevalent self-assessed health in the two countries took
the form EQ-5DCHILE = 0.773*EQ-5DUS-H + 10.301 CONCLU-
SION: Should this relationship in values for self-classiﬁed EQ-
5D health states prove to be stable, then it could be used as a
conversion factor to estimate values for EQ-5D in Chile from
values obtained from Hispanic respondents in the US national
survey. Data from surveys reporting values for actual health
states appear to be useful in recalibrating scales of value for
hypothetical health states.
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CONSISTENCY OF MINIMAL IMPORTANT DIFFERENCES 
FOR MAPPED UTILITY INSTRUMENTS IN FOUR MAJOR
PATIENT GROUPS
Nichol MB, Epstein JD, Dow TD
University of Southern California, Los Angeles, CA, USA
OBJECTIVES: It is unknown whether minimal important dif-
ferences (MID) identiﬁed on generic patient reported outcomes
are consistent across disease states. This research compares
mapped utility instrument MID values within four newly identi-
ﬁed patient groups. METHODS: Retrospective analysis of a 
two-year longitudinal study in a Western US managed care 
population was conducted. Individuals receiving a prescription
for a new disease state in either year were selected. Four major
disease states, each with more than 100 patients reporting a
minimal change in health over the past year on the SF-36 general
health question were included. MID values were calculated for
gains and losses in health on the Brazier, Lundberg, Nichol, and
Shmueli mapped utility instruments. MID values between disease
groups for each instrument were tested with ANOVA. Effect
sizes were compared in accordance to Norman (2001) as a dis-
tribution-based method to determine the MID. RESULTS:
Results are displayed for Brazier’s SF-6D measure as all mapped
utility instruments had similar results. 145, 240, 306, and 150
patients reported a minimal gain or loss in health over the year
when they ﬁlled a new prescription for cardiac disease, COPD,
depression and rheumatoid arthritis, respectively. The reported
mean MID utility change for gains was 0.026, 0.022, 0.019, and
0.018 for each patient group, respectively (P = 0.975). The
reported mean MID utility change for losses was −0.069, −0.045,
−0.055, and −0.028 for each patient group, respectively (P =
0.217). The average effect sizes ranged from 0.133 and 0.194
for gains and from −0.241 and −0.627 for losses. Therefore,
according to Cohen’s classiﬁcation system, the MID values in
gains were not signiﬁcant changes, while those in losses were
considered small. CONCLUSION: This data demonstrates con-
sistent, but small, MID values across various disease groups for
each utility instrument. Researchers should conﬁrm results in
other populations.
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PSYCHOMETRIC EVALUATION OF INSTRUMENTS 
USED TO MEASURE PATIENT SATISFACTION WITH
PHARMACIST SERVICES
Rollins B, Franic DM
University of Georgia, Athens, GA, USA
OBJECTIVES: Evaluate the practical and psychometric proper-
ties of the instruments used to measure patient satisfaction with
pharmacist cognitive services, including medication therapy
management and patient counseling. METHODS: After a com-
prehensive literature review, instruments were included based on:
at least one peer-reviewed publication using the instrument, ref-
erence lists, instrument availability, and a focus on pharmacist
cognitive services. The six measurement criteria used were: prac-
tical features (administration time), breadth (multidimensional
construct), depth (ﬂoor and ceiling effects), internal consistency
(coefﬁcient alpha > 0.7) and test-retest reliability (r > 0.7), and
validity. Measurement evaluation was based on McHorney and
Tarlov’s (1995) criteria for evaluation of outcome measurements
and the recent Food and Drug Administration guide on patient
reported outcome measures (2006). RESULTS: Of the 22 instru-
ments identiﬁed, ﬁve were excluded because satisfaction was not
measured as a multidimensional construct. Of the remaining 17
instruments, none met all six study criteria. A majority of the
studies focused on patients’ interaction with the pharmacist in a
community pharmacy setting. Instruments were notable for the
lack of reported psychometric data, especially test-retest relia-
bility, which was reported in only one instrument. Only nine of
17 instruments reported internal consistency measures, but the
nine reporting met study criteria (alpha > 0.7). The series of
instruments developed by MacKeigan and Larson (1989, 1994,
